These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15149642)

  • 21. Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton.
    Gitto R; Caruso R; Pagano B; De Luca L; Citraro R; Russo E; De Sarro G; Chimirri A
    J Med Chem; 2006 Sep; 49(18):5618-22. PubMed ID: 16942035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vitro cytotoxicity of 1,2,3,4-tetrahydroisoquinoline derivatives.
    Saitoh T; Abe K; Ishikawa M; Nakatani M; Shimazu S; Satoh N; Yoneda F; Taguchi K; Horiguchi Y
    Eur J Med Chem; 2006 Feb; 41(2):241-52. PubMed ID: 16412536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, pharmacological characterization, and quantitative structure-activity relationship analyses of 3,7,9,9-tetraalkylbispidines: derivatives with specific bradycardic activity.
    Schön U; Antel J; Brückner R; Messinger J; Franke R; Gruska A
    J Med Chem; 1998 Jan; 41(3):318-31. PubMed ID: 9464363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and evaluation of 2,6-piperidinedione derivatives as potentially novel compounds with analgesic and other CNS activities.
    El Batran SA; Osman AE; Ismail MM; El Sayed AM
    Inflammopharmacology; 2006 Mar; 14(1-2):62-71. PubMed ID: 16835715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (3S)-N-(L-Aminoacyl)-1,2,3,4-tetrahydroisoquinolines, a class of novel antithrombotic agents: synthesis, bioassay, 3D QSAR, and ADME analysis.
    Zheng M; Zhang X; Zhao M; Chang HW; Wang W; Wang Y; Peng S
    Bioorg Med Chem; 2008 Nov; 16(21):9574-87. PubMed ID: 18835178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of potent and selective small-molecule human Urotensin-II antagonists.
    McAtee JJ; Dodson JW; Dowdell SE; Girard GR; Goodman KB; Hilfiker MA; Sehon CA; Sha D; Wang GZ; Wang N; Viet AQ; Zhang D; Aiyar NV; Behm DJ; Carballo LH; Evans CA; Fries HE; Nagilla R; Roethke TJ; Xu X; Yuan CC; Douglas SA; Neeb MJ
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3500-3. PubMed ID: 18502123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3,4-trans-4-Aryl-3-(1-pyridinio)-1,2,3,4-tetrahydropyridine-6-thiolates--new group of potential cardiotonic drugs.
    Krauze A; Vītoliņa R; Garaliene V; Sīle L; Klusa V; Duburs G
    Eur J Med Chem; 2005 Nov; 40(11):1163-7. PubMed ID: 15927309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses of new substituted triazino tetrahydroisoquinolines and beta-carbolines as novel antileishmanial agents.
    Kumar A; Katiyar SB; Gupta S; Chauhan PM
    Eur J Med Chem; 2006 Jan; 41(1):106-13. PubMed ID: 16356594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
    Yang J; Hua WY; Wang FX; Wang ZY; Wang X
    Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Syntheses of tetrahydroisoquinoline derivatives that inhibit NO production in activated BV-2 microglial cells.
    Seo JW; Srisook E; Son HJ; Hwang O; Cha YN; Chi DY
    Eur J Med Chem; 2008 Jun; 43(6):1160-70. PubMed ID: 17980460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of 2-(4-substitutedmethylpiperazin-1-yl)-N-(3,4-dihydro-3-oxo-2H-benzo[b][1,4]oxazin-7-yl)acetamides and their positive inotropic evaluation.
    Liu XK; Cui X; Hong L; Sun LP; Quan ZS; Piao HR
    Eur J Med Chem; 2009 Jul; 44(7):3027-31. PubMed ID: 18824278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents.
    Chen KX; Xie HY; Li ZG; Gao JR
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5381-6. PubMed ID: 18835162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and in vitro anthelmintic activity against Nippostrongylus brasiliensis of new 2-amino-4-hydroxy-delta-valerolactam derivatives.
    Gordon S; Costa L; Incerti M; Manta E; Saldaña J; Domínguez L; Mariezcurrena R; Suescun L
    Farmaco; 1997 Oct; 52(10):603-8. PubMed ID: 9580122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bioactivity diversity and functional mechanism of tetrahydroisoquinoline alkaloids].
    Liu CJ; Liu DY; Xiang L
    Yao Xue Xue Bao; 2010 Jan; 45(1):9-16. PubMed ID: 21351443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vitro microbiological evaluation of imidazo(4,5-b)pyridinylethoxypiperidones.
    Aridoss G; Balasubramanian S; Parthiban P; Kabilan S
    Eur J Med Chem; 2006 Feb; 41(2):268-75. PubMed ID: 16380194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological activity of sulphostin analogues, novel dipeptidyl peptidase IV inhibitors.
    Abe M; Akiyama T; Umezawa Y; Yamamoto K; Nagai M; Yamazaki H; Ichikawa Y; Muraoka Y
    Bioorg Med Chem; 2005 Feb; 13(3):785-97. PubMed ID: 15653346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a series of tetrahydroisoquinoline derivatives as potential therapeutic agents for breast cancer.
    Lin HR; Safo MK; Abraham DJ
    Bioorg Med Chem Lett; 2007 May; 17(9):2581-9. PubMed ID: 17337183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrahydroisoquinolines as dopaminergic ligands: 1-Butyl-7-chloro-6-hydroxy-tetrahydroisoquinoline, a new compound with antidepressant-like activity in mice.
    Berenguer I; El Aouad N; Andujar S; Romero V; Suvire F; Freret T; Bermejo A; Ivorra MD; Enriz RD; Boulouard M; Cabedo N; Cortes D
    Bioorg Med Chem; 2009 Jul; 17(14):4968-80. PubMed ID: 19540762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds.
    Das U; Alcorn J; Shrivastav A; Sharma RK; De Clercq E; Balzarini J; Dimmock JR
    Eur J Med Chem; 2007 Jan; 42(1):71-80. PubMed ID: 16996657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.